Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback